Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.90
Delayed Data
As of May 01
 +0.24 / +2.25%
Today’s Change
10.33
Today|||52-Week Range
18.48
-22.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.

Contact Information

Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York New York 10022
P:(212) 531-5965
Investor Relations:
(212) 531-5962

Employees

Shareholders

Mutual fund holders42.23%
Other institutional36.84%
Individual stakeholders14.42%

Top Executives

Gregory P. MadisonPresident, Chief Operating Officer & Director
James F. OlivieroChief Financial Officer
Enrique PoradosuVice President-Scientific & Business Strategy
Amit SharmaVice President-Medical Affairs
Douglass H. LaidlawDirector-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account